oxoglaucine has been researched along with apomorphine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanovska, N; Philipov, S | 1 |
| Chang, FR; Teng, CM; Wei, JL; Wu, YC | 1 |
| Hristova, M; Ivanovska, N; Philipov, S | 1 |
| Hristova, M; Ivanovska, N | 1 |
| Dimitrova, P; Ivanovska, N; Philipov, S; Remichkova, M | 1 |
| Chen, ZF; Geng, B; Hong, X; Liang, H; Liu, YC; Peng, Y; Shi, YF | 1 |
| Duan, X; Liu, Y; Lu, Z; Sun, W; Tu, P; Yang, Z | 1 |
| Chen, ZF; Geng, B; Huang, KB; Liang, H; Liu, YC; Shi, YF | 1 |
| Arita, M; Galabov, AS; Philipov, S | 1 |
| Chen, ZF; Jiang, YH; Khan, TM; Li, ZQ; Liang, H; Liu, YC; Qin, JL; Shen, WY; Wang, M; Wei, JH | 1 |
| Galabov, AS; Nikolova, I; Stoyanova, A | 1 |
| Galabov, AS; Vassileva-Pencheva, R | 1 |
| Dimitrov, V; Dobrikov, G; Galabov, AS; Nikolova, I; Philipov, S; Pürstinger, G; Stoyanova, A | 1 |
| Galabov, AS; Stoyanova, A | 1 |
| Chen, F; Long, H; Yu, Y; Zhong, G | 1 |
| Eid, N; Ito, Y | 1 |
16 other study(ies) available for oxoglaucine and apomorphine
| Article | Year |
|---|---|
A low dose immunorestorative effect of aporphinoid alkaloid oxoglaucine on experimentally immunosuppressed and infected mice.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Apomorphine; Artemisinins; Cyclophosphamide; Drug Interactions; Erythrocytes; Hypersensitivity, Delayed; Immunosuppressive Agents; Indomethacin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Prednisolone; Sesquiterpenes; Sheep | 1997 |
Antiplatelet aggregation constituents from Annona purpurea.
Topics: Alkaloids; Animals; Apomorphine; Aporphines; Chromatography, High Pressure Liquid; In Vitro Techniques; Plants, Medicinal; Platelet Aggregation Inhibitors; Rabbits; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 1998 |
Immunosuppression and recovery of drug-impaired host resistance against Candida albicans infection by oxoglaucine.
Topics: Animals; Apomorphine; Brain; Candidiasis; Cyclophosphamide; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Kidney; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred ICR | 2000 |
Treatment with oxoglaucine can enhance host resistance to Candida albicans infection of mice with adjuvant arthritis.
Topics: Adjuvants, Immunologic; Animals; Apomorphine; Arthritis, Experimental; Biological Assay; Candida albicans; Candidiasis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Mice; Tumor Necrosis Factor-alpha | 2000 |
Toll-like receptor-mediated anti-inflammatory action of glaucine and oxoglaucine.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Apomorphine; Aporphines; Cytokines; Immunity; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Nitric Oxide; Papaveraceae; Plant Components, Aerial; Plant Extracts; Structure-Activity Relationship; Toll-Like Receptors; Zymosan | 2009 |
TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apomorphine; Cattle; Cell Cycle; Cell Line; Coordination Complexes; Crystallography, X-Ray; DNA; DNA Topoisomerases, Type I; Drugs, Chinese Herbal; Humans; Models, Molecular; Neoplasms; Topoisomerase I Inhibitors; Transition Elements | 2012 |
[Chemical constituents from Corydalis yanhusuo].
Topics: Adenosine; Alkaloids; Apomorphine; Aporphines; Berberine; Berberine Alkaloids; Chromatography, Liquid; Corydalis; Plant Extracts; Spectrometry, Mass, Electrospray Ionization | 2012 |
Oxoglaucine-lanthanide complexes: synthesis, crystal structure and cytotoxicity.
Topics: Apomorphine; Apoptosis; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Lanthanoid Series Elements; Models, Molecular; Neoplasms; Tumor Cells, Cultured | 2014 |
Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A.
Topics: Antiviral Agents; Apomorphine; Brefeldin A; Humans; Phosphotransferases (Alcohol Group Acceptor); Poliovirus; Quercetin; Virus Replication | 2015 |
Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.
Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium | 2015 |
Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Brain; Central Nervous System Infections; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Survival Analysis; Treatment Outcome | 2015 |
Effectiveness of the Consecutive Alternating Administration Course of a Triple Antiviral Combination in Coxsackievirus B3 Infections in Mice.
Topics: Animals; Animals, Newborn; Antiviral Agents; Apomorphine; Coxsackievirus Infections; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Isoxazoles; Mice; Mice, Inbred ICR | 2016 |
Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Cells, Cultured; Coxsackievirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2015 |
Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.
Topics: Animals; Antiviral Agents; Apomorphine; Cell Line; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2020 |
Oxoglaucine mediates Ca
Topics: Animals; Apomorphine; Autophagy; Calcium; Calmodulin; Cells, Cultured; Chondrocytes; Humans; Osteoarthritis; Rats; TRPV Cation Channels | 2021 |
Oxoglaucine alleviates osteoarthritis by activation of autophagy via blockade of Ca
Topics: Apomorphine; Autophagy; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Humans; Osteoarthritis; TRPV Cation Channels | 2022 |